GlassScriptPhysician profile
Amanda Pauley
NPI 1366603383
$25,800.93
in general payments reported to CMS, 2019-2025
21 companies · $1,622 in 2025
The $1,622 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,434 · 2020: $1,427 · 2021: $6,655 · 2022: $1,895 · 2023: $6,027 · 2024: $5,741 · 2025: $1,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Food and Beverage: $434 · Education: $98.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,857.13 |
| Food and Beverage | $433.92 |
| Education | $98.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18,995.99 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $5,970.56 | 2019-2021 | |
| Intuitive Surgical, INC. | $298.51 | 2019-2023 | Da Vinci Surgical System |
| Amgen INC. | $59.11 | 2019-2024 | Tezspire |
| Novo Nordisk INC | $57.81 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $50.99 | 2019-2024 | Trelegy Ellipta |
| Coopersurgical, INC. | $49.88 | 2019-2020 | |
| Lilly USA, LLC | $42.01 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $41.33 | 2019-2020 | |
| Applied Medical Resources Corporation | $33.11 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $30.65 | 2025 | Farxiga |
| Daiichi Sankyo INC. | $25.97 | 2023 | Injectafer |
| Shield Therapeutics INC | $23.17 | 2024 | |
| Astellas Pharma US INC | $21.66 | 2025 | Veozah |
| Paratek Pharmaceuticals, INC. | $18.81 | 2025 | Nuzyra, Xhance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.58 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $16.37 | 2019 | |
| Acessa Health INC. | $12.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.09 | 2019 | |
| Pfizer INC. | $11.77 | 2021 | |
| Amag Pharmaceuticals, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Pauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.